Llano DA

References (2)

Title : Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease - Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
Author(s) : Lenz RA , Pritchett YL , Berry SM , Llano DA , Han S , Berry DA , Sadowsky CH , Abi-Saab WM , Saltarelli MD
Ref : Alzheimer Disease & Associated Disorders , 29 :192 , 2015
Abstract : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
ESTHER : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
PubMedSearch : Lenz_2015_Alzheimer.Dis.Assoc.Disord_29_192
PubMedID: 25973909

Title : Pharmacokinetic modeling and [(1)(2)(3)]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089 - Chin_2011_J.Pharmacol.Exp.Ther_336_716
Author(s) : Chin CL , Carr RA , Llano DA , Barret O , Xu H , Batis J , Koren AO , Seibyl JP , Marsh KC , Tamagnan G , Decker MW , Day M , Fox GB
Ref : Journal of Pharmacology & Experimental Therapeutics , 336 :716 , 2011
Abstract : Chin_2011_J.Pharmacol.Exp.Ther_336_716
ESTHER : Chin_2011_J.Pharmacol.Exp.Ther_336_716
PubMedSearch : Chin_2011_J.Pharmacol.Exp.Ther_336_716
PubMedID: 21172907